Hong Jun Cho

Hong Jun Cho is a Senior Research Scientist at Pfizer, specializing in conjugate vaccines through polysaccharide modification and protein conjugation. With extensive experience in synthetic and medicinal chemistry, Cho has contributed to the development of small molecule libraries aimed at treating Alzheimer's disease and has led research projects in cancer imaging and therapy. Cho previously held postdoctoral positions at the University of Illinois, the Korea Institute of Science and Technology, and the NIH Clinical Center, where they focused on drug design and in vivo evaluations. Educationally, Cho earned a Bachelor’s degree and a PhD in Chemical and Biological Engineering from Seoul National University.